| Year |
Citation |
Score |
| 2024 |
Kapic A, Sabnis N, Dossou AS, Chavez J, Ceresa L, Gryczynski Z, Fudala R, Dickerman R, Bunnell BA, Lacko AG. Photophysical Characterization and In Vitro Evaluation of α-Mangostin-Loaded HDL Mimetic Nano-Complex in LN-229 Glioblastoma Spheroid Model. International Journal of Molecular Sciences. 25. PMID 39000485 DOI: 10.3390/ijms25137378 |
0.354 |
|
| 2024 |
Sabnis N, Raut S, Nagarajan B, Kapic A, Dossou AS, Lothstein L, Fudala R, Bunnell BA, Lacko AG. A Spontaneous Assembling Lipopeptide Nanoconjugate Transporting the Anthracycline Drug -Benzyladriamycin-14-valerate for Personalized Therapy of Ewing Sarcoma. Bioconjugate Chemistry. PMID 38318778 DOI: 10.1021/acs.bioconjchem.3c00429 |
0.32 |
|
| 2020 |
Dossou AS, Sabnis N, Nagarajan B, Mathew E, Fudala R, Lacko AG. Lipoproteins and the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1272: 93-116. PMID 32845504 DOI: 10.1007/978-3-030-48457-6_6 |
0.314 |
|
| 2020 |
Raut SG, Garud A, Nagarajan B, Sabnis N, Remaley A, Fudala R, Gryczynski I, Gryczynski Z, Dzyuba SV, Borejdo J, Lacko AG. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles, using Intrinsic Fluorescence. The Journal of Pharmacology and Experimental Therapeutics. PMID 31941718 DOI: 10.1124/Jpet.119.262899 |
0.469 |
|
| 2020 |
Dossou AS, Sabnis N, Lacko AG. Characterization of DMXAA‐Loaded Reconstituted High‐Density Lipoprotein Nanoparticles The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.03737 |
0.377 |
|
| 2019 |
Chen X, Mangala LS, Mooberry L, Bayraktar E, Dasari SK, Ma S, Ivan C, Court KA, Rodriguez-Aguayo C, Bayraktar R, Raut S, Sabnis N, Kong X, Yang X, Lopez-Berestein G, ... Lacko AG, et al. Identifying and targeting angiogenesis-related microRNAs in ovarian cancer. Oncogene. PMID 31289363 DOI: 10.1038/S41388-019-0862-Y |
0.735 |
|
| 2019 |
Berney E, Sabnis N, Panchoo M, Raut S, Dickerman R, Lacko AG. The SR-B1 Receptor as a Potential Target for Treating Glioblastoma. Journal of Oncology. 2019: 1805841. PMID 31275377 DOI: 10.1155/2019/1805841 |
0.462 |
|
| 2018 |
Isaac-Olivé K, Ocampo-García BE, Aranda-Lara L, Santos-Cuevas CL, Jiménez-Mancilla NP, Luna-Gutiérrez MA, Medina LA, Nagarajan B, Sabnis N, Raut S, Prokai L, Lacko AG. [Tc-HYNIC-N-dodecylamide]: a new hydrophobic tracer for labelling reconstituted high-density lipoproteins (rHDL) for radioimaging. Nanoscale. PMID 30543234 DOI: 10.1039/C8Nr07484D |
0.467 |
|
| 2018 |
Raut S, Mooberry L, Sabnis N, Garud A, Dossou AS, Lacko A. Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy. Frontiers in Pharmacology. 9: 1154. PMID 30374303 DOI: 10.3389/Fphar.2018.01154 |
0.779 |
|
| 2018 |
Raut S, Dasseux JL, Sabnis NA, Mooberry L, Lacko A. Lipoproteins for therapeutic delivery: recent advances and future opportunities. Therapeutic Delivery. PMID 29495929 DOI: 10.4155/Tde-2017-0122 |
0.782 |
|
| 2017 |
Xiong F, Nirupama S, Sirsi SR, Lacko A, Hoyt K. Ultrasound-Stimulated Drug Delivery Using Therapeutic Reconstituted High-Density Lipoprotein Nanoparticles. Nanotheranostics. 1: 440-449. PMID 29188177 DOI: 10.7150/ntno.21905 |
0.316 |
|
| 2017 |
Panchoo M, Lacko A. Scavenger receptor class B type 1 regulates neuroblastoma cell proliferation, migration and invasion. Biochemical and Biophysical Research Communications. 495: 614-620. PMID 29128352 DOI: 10.1016/J.Bbrc.2017.10.154 |
0.411 |
|
| 2017 |
Johnson R, Sabnis N, Sun X, Ahluwalia R, Lacko AG. SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer. Breast Cancer (Dove Medical Press). 9: 383-392. PMID 28670138 DOI: 10.2147/BCTT.S131038 |
0.394 |
|
| 2017 |
Sabnis S, Sabnis NA, Raut S, Lacko AG. Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery. International Journal of Nanomedicine. 12: 1453-1464. PMID 28260891 DOI: 10.2147/Ijn.S122036 |
0.487 |
|
| 2017 |
Ray A, Nagarajan B, Sankpal UT, Shelake S, Bowman WP, Lacko A, Basha RM. Abstract 1532: Mithramycin induces the antiproliferative activity of chemotherapeutic agents in Ewing sarcoma cells Cancer Research. 77: 1532-1532. DOI: 10.1158/1538-7445.Am2017-1532 |
0.34 |
|
| 2016 |
Mooberry LK, Sabnis NA, Panchoo M, Nagarajan B, Lacko AG. Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging. Frontiers in Pharmacology. 7: 466. PMID 28018216 DOI: 10.3389/Fphar.2016.00466 |
0.779 |
|
| 2015 |
Shah S, Chib R, Raut S, Bermudez J, Sabnis N, Duggal D, Kimball JD, Lacko AG, Gryczynski Z, Gryczynski I. Photophysical characterization of anticancer drug valrubicin in rHDL nanoparticles and its use as an imaging agent. Journal of Photochemistry and Photobiology. B, Biology. 155: 60-65. PMID 26735001 DOI: 10.1016/J.Jphotobiol.2015.12.007 |
0.47 |
|
| 2015 |
Lacko AG, Sabnis NA, Nagarajan B, McConathy WJ. HDL as a drug and nucleic acid delivery vehicle. Frontiers in Pharmacology. 6: 247. PMID 26578957 DOI: 10.3389/Fphar.2015.00247 |
0.518 |
|
| 2015 |
Sabnis N, Bowman WP, Lacko AG. Lipoprotein based drug delivery: Potential for pediatric cancer applications World Journal of Pharmacology. 4: 172. DOI: 10.5497/WJP.V4.I2.172 |
0.343 |
|
| 2015 |
Johnson R, Lacko A. Abstract B54: SR-B1 directed nanoparticles in targeted therapy for the treatment of metastatic triple-negative breast cancer Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-B54 |
0.477 |
|
| 2015 |
Ajit Shah S, Chib R, Raut S, Bermudez J, Sabnis N, Duggal D, Lacko A, Gryczynski Z, Gryczynski I. A Comparison of Photophysical Characteristics of rHDL Encapsulated Anti-Cancer Drug Valrubicin and Free Valrubicin Biophysical Journal. 108: 623a. DOI: 10.1016/J.Bpj.2014.11.3389 |
0.471 |
|
| 2014 |
Basha R, Sabnis N, Heym K, Bowman WP, Lacko AG. Targeted nanoparticles for pediatric leukemia therapy. Frontiers in Oncology. 4: 101. PMID 24860784 DOI: 10.3389/Fonc.2014.00101 |
0.447 |
|
| 2013 |
Sabnis N, Pratap S, Akopova I, Bowman PW, Lacko AG. Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma. Frontiers in Pediatrics. 1: 6. PMID 24459664 DOI: 10.3389/Fped.2013.00006 |
0.45 |
|
| 2013 |
Johnson R, Sabnis N, McConathy WJ, Lacko AG. The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer. Pharmaceutics. 5: 353-70. PMID 24244833 DOI: 10.3390/Pharmaceutics5020353 |
0.328 |
|
| 2013 |
Cruz PM, Mo H, McConathy WJ, Sabnis N, Lacko AG. The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Frontiers in Pharmacology. 4: 119. PMID 24093019 DOI: 10.3389/Fphar.2013.00119 |
0.522 |
|
| 2012 |
Sabnis N, Lacko AG. Drug delivery via lipoprotein-based carriers: answering the challenges in systemic therapeutics. Therapeutic Delivery. 3: 599-608. PMID 22834404 DOI: 10.4155/Tde.12.41 |
0.529 |
|
| 2012 |
Sabnis N, Nair M, Israel M, McConathy WJ, Lacko AG. Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles International Journal of Nanomedicine. 7: 975-983. PMID 22393294 DOI: 10.2147/Ijn.S28029 |
0.4 |
|
| 2012 |
Sabnis N, Lacko AG. Erratum: Drug delivery via lipoprotein-based carriers: Answering the challenges in systemic therapeutics (Therapeutic Delivery (2012) 3:5 (599-608)) Therapeutic Delivery. 3. DOI: 10.4155/Tde.12.65 |
0.411 |
|
| 2011 |
McConathy WJ, Paranjape S, Mooberry L, Buttreddy S, Nair M, Lacko AG. Validation of the reconstituted high-density lipoprotein (rHDL) drug delivery platform using dilauryl fluorescein (DLF). Drug Delivery and Translational Research. 1: 113-20. PMID 25788110 DOI: 10.1007/S13346-010-0012-0 |
0.795 |
|
| 2011 |
Shahzad MM, Mangala LS, Han HD, Lu C, Bottsford-Miller J, Nishimura M, Mora EM, Lee JW, Stone RL, Pecot CV, Thanapprapasr D, Roh JW, Gaur P, Nair MP, Park YY, ... ... Lacko AG, et al. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. Neoplasia (New York, N.Y.). 13: 309-19. PMID 21472135 DOI: 10.1593/Neo.101372 |
0.484 |
|
| 2010 |
Sarkar P, Luchowski R, Raut S, Sabnis N, Remaley A, Lacko AG, Thamake S, Gryczynski Z, Gryczynski I. Studies on solvatochromic properties of aminophenylstyryl-quinolinum dye, LDS 798, and its application in studying submicron lipid based structure. Biophysical Chemistry. 153: 61-9. PMID 21041016 DOI: 10.1016/J.Bpc.2010.10.005 |
0.343 |
|
| 2010 |
Mooberry LK, Nair M, Paranjape S, McConathy WJ, Lacko AG. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier. Journal of Drug Targeting. 18: 53-8. PMID 19637935 DOI: 10.3109/10611860903156419 |
0.784 |
|
| 2010 |
Shahzad MM, Mangala LS, Lee JW, Matsuo K, Nair MP, Han HD, Mora EM, Lu C, Gaur P, Haghpeykar SB, Carroll AR, Stone RL, Lopez-Berestein G, Lacko AG, Sood AK. Abstract 5517: Targeting anticancer therapeutics: A role for reconstituted high density lipoprotein (rHDL) Cancer Research. 70: 5517-5517. DOI: 10.1158/1538-7445.Am10-5517 |
0.387 |
|
| 2008 |
McConathy WJ, Nair MP, Paranjape S, Mooberry L, Lacko AG. Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel. Anti-Cancer Drugs. 19: 183-8. PMID 18176115 DOI: 10.1097/Cad.0B013E3282F1Da86 |
0.768 |
|
| 2007 |
Lackó AG, Stewart DR, McClain R, Prókai L, McConathy WJ. Recent developments and patenting of lipoprotein based formulations. Recent Patents On Drug Delivery & Formulation. 1: 143-5. PMID 19075881 DOI: 10.2174/187221107780831914 |
0.457 |
|
| 2007 |
Lacko AG, Nair M, Prokai L, McConathy WJ. Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs. Expert Opinion On Drug Delivery. 4: 665-75. PMID 17970668 DOI: 10.1517/17425247.4.6.665 |
0.496 |
|
| 2007 |
Singhal SS, Singhal J, Nair MP, Lacko AG, Awasthi YC, Awasthi S. Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer. International Journal of Oncology. 30: 717-25. PMID 17273774 DOI: 10.3892/Ijo.30.3.717 |
0.323 |
|
| 2006 |
Reshetnyak Y, Tchedre KT, Nair MP, Pritchard PH, Lacko AG. Structural differences between wild-type and fish eye disease mutant of lecithin:cholesterol acyltransferase. Journal of Biomolecular Structure & Dynamics. 24: 75-82. PMID 16780378 DOI: 10.1080/07391102.2006.10507101 |
0.366 |
|
| 2006 |
Lacko AG, Nair M, Paranjape S, Mooberry L, McConathy WJ. Trojan horse meets magic bullet to spawn a novel, highly effective drug delivery model. Chemotherapy. 52: 171-3. PMID 16691026 DOI: 10.1159/000093268 |
0.769 |
|
| 2004 |
Lane SB, Tchedre KT, Nair MP, Thigpen AE, Lacko AG. Characterization of lecithin:cholesterol acyltransferase expressed in a human lung cell line. Protein Expression and Purification. 36: 157-64. PMID 15249036 DOI: 10.1016/J.Pep.2004.03.009 |
0.359 |
|
| 2004 |
Kim H, Jacobson EL, Jacobson MK, Lacko AG. ApoA-1 Milano and regression of atherosclerosis. Jama. 291: 1319; author reply 1. PMID 15026388 DOI: 10.1001/Jama.291.11.1319-A |
0.375 |
|
| 2002 |
Lacko AG, Nair M, Paranjape S, Johnso S, McConathy WJ. High density lipoprotein complexes as delivery vehicles for anticancer drugs. Anticancer Research. 22: 2045-9. PMID 12174882 |
0.407 |
|
| 2001 |
Murray KR, Nair MP, Ayyobi AF, Hill JS, Pritchard PH, Lacko AG. Probing the 121-136 domain of lecithin:cholesterol acyltransferase using antibodies. Archives of Biochemistry and Biophysics. 385: 267-75. PMID 11368007 DOI: 10.1006/Abbi.2000.2154 |
0.617 |
|
| 2001 |
Kálmán J, Kudchodkar BJ, Krishnamoorthy R, Dory L, Lacko AG, Agarwal N. High cholesterol diet down regulates the activity of activator protein-1 but not nuclear factor-kappa B in rabbit brain Life Sciences. 68: 1495-1503. PMID 11253166 DOI: 10.1016/S0024-3205(01)00955-9 |
0.364 |
|
| 2000 |
Kudchodkar BJ, Lacko AG, Dory L, Fungwe TV. Dietary fat modulates serum paraoxonase 1 activity in rats Journal of Nutrition. 130: 2427-2433. PMID 11015468 DOI: 10.1093/Jn/130.10.2427 |
0.308 |
|
| 2000 |
Kudchodkar BJ, Wilson J, Lacko A, Dory L. Hyperbaric oxygen reduces the progression and accelerates the regression of atherosclerosis in rabbits Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 1637-1643. PMID 10845883 DOI: 10.1161/01.Atv.20.6.1637 |
0.38 |
|
| 2000 |
Ayyobi AF, Lacko AG, Murray K, Nair M, Li M, Molhuizen HOF, Pritchard PH. Biochemical and compositional analyses of recombinant lecithin:cholesterol acyltransferase (LCAT) obtained from a hepatic source Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids. 1484: 1-13. PMID 10685026 DOI: 10.1016/S1388-1981(99)00199-7 |
0.651 |
|
| 1999 |
Kálmán J, Kudchodkar BJ, Murray K, McConathy WJ, Juhász A, Janka Z, Lacko AG. Evaluation of serum-lipid-related cardiovascular risk factors in Alzheimer's disease Dementia and Geriatric Cognitive Disorders. 10: 488-493. PMID 10559565 DOI: 10.1159/000017195 |
0.625 |
|
| 1999 |
Murray KR, Nair MP, McConathy WJ, Lacko AG. Enzyme linked immunoassay (ELISA) for lecithin:cholesterol acyltransferase (LCAT) Analytical Letters. 32: 1553-1564. DOI: 10.1080/00032719908542915 |
0.604 |
|
| 1998 |
Lacko AG, Kudchodkar BJ, Loney WW, Clearfield MB, Weis S. Decrease in high density lipoprotein cholesterol (HDL-C) levels following gemfibrozil therapy. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 36: 389-92. PMID 9711427 DOI: 10.1515/Cclm.1998.066 |
0.424 |
|
| 1997 |
Loney WW, Kudchodkar BJ, Weis S, Clearfield MB, Shores J, Lacko AG. Evaluation of gemfibrozil therapy: predictive response from lipoprotein subfraction analysis. American Journal of Therapeutics. 4: 301-9. PMID 10423623 DOI: 10.1097/00045391-199709000-00004 |
0.375 |
|
| 1997 |
Nair MP, Kudchodkar BJ, Pritchard PH, Lacko AG. Purification of recombinant lecithin:cholesterol acyltransferase Protein Expression and Purification. 10: 38-41. PMID 9179288 DOI: 10.1006/Prep.1996.0711 |
0.355 |
|
| 1996 |
Hasler-Rapacz J, Kempen HJ, Princen HMG, Kudchodkar BJ, Lacko AG, Rapacz J. Effects of Simvastatin on Plasma Lipids and Apolipoproteins in Familial Hypercholesterolemic Swine Arteriosclerosis, Thrombosis, and Vascular Biology. 16: 137-143. PMID 8548414 DOI: 10.1161/01.Atv.16.1.137 |
0.383 |
|
| 1994 |
Lacko AG, Pritchard PH. 2nd International Symposium on Reverse Cholesterol Transport: Report on a meeting Journal of Lipid Research. 35: 351-356. PMID 8169538 |
0.311 |
|
| 1994 |
Clearfield MB, Lee N, Armstrong L, DeFazio P, Kudchodkar BJ, Lacko AG. The effect of captopril on the oxidation of plasma lipoproteins Pharmacology and Toxicology. 75: 218-221. PMID 7800666 DOI: 10.1111/J.1600-0773.1994.Tb00350.X |
0.355 |
|
| 1994 |
Lacko AG. The metabolism of high-density lipoproteins Trends in Cardiovascular Medicine. 4: 84-88. DOI: 10.1016/1050-1738(94)90014-0 |
0.437 |
|
| 1992 |
Lee Sm, Kudchodkar BJ, Lacko AG. Effect of ethinyl estradiol treatment on lipoproteins and LCAT activity in aged rats Mechanisms of Ageing and Development. 64: 123-131. PMID 1630152 DOI: 10.1016/0047-6374(92)90101-I |
0.36 |
|
| 1992 |
Bleicher JM, Lacko AG. Physiologic role and clinical significance of reverse cholesterol transport Journal of the American Osteopathic Association. 92: 625-632. PMID 1601697 |
0.308 |
|
| 1992 |
Lacko AG, Lee SM, Mirshahi I, Hasler-Rapacz J, Kudchodkar BJ. Decreased lecithin: Cholesterol acyltransferase activity in the plasma of hypercholesterolemic pigs Lipids. 27: 266-269. PMID 1518383 DOI: 10.1007/Bf02536473 |
0.323 |
|
| 1991 |
Lee SM, Kudchodkar BJ, Lacko AG. Age related changes in the lipoprotein substrates for the esterification of plasma cholesterol in rats Mechanisms of Ageing and Development. 61: 85-98. PMID 1779703 DOI: 10.1016/0047-6374(91)90008-N |
0.395 |
|
| 1990 |
Lacko AG, Pritchard PH. International Symposium on Reverse Cholesterol transport. Report on a meeting Journal of Lipid Research. 31: 2295-2299. PMID 1982532 |
0.328 |
|
| 1989 |
Sparks DL, Frohlich J, Lacko AG, Pritchard PH. Relationship between cholesteryl ester transfer activity and high density lipoprotein composition in hyperlipidemic patients. Atherosclerosis. 77: 183-91. PMID 2751750 DOI: 10.1016/0021-9150(89)90080-4 |
0.377 |
|
| 1988 |
Pritchard PH, McLeod R, Frohlich J, Park MC, Kudchodkar BJ, Lacko AG. Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease) Biochimica Et Biophysica Acta (Bba)/Lipids and Lipid Metabolism. 958: 227-234. PMID 3122840 DOI: 10.1016/0005-2760(88)90181-6 |
0.407 |
|
| 1987 |
Park MSC, Kudchodkar BJ, Frohlich J, Pritchard H, Lacko AG. Study of the components of reverse cholesterol transport in lecithin: Cholesterol acyltransferase deficiency Archives of Biochemistry and Biophysics. 258: 545-554. PMID 3674887 DOI: 10.1016/0003-9861(87)90376-6 |
0.43 |
|
| 1986 |
Carlile SI, Kudchodkar BJ, Wang CS, Lacko AG. Age-related changes in the rate of esterification of plasma cholesterol in Fischer-344 rats. Mechanisms of Ageing and Development. 33: 211-20. PMID 3959602 DOI: 10.1016/0047-6374(86)90028-X |
0.351 |
|
| 1986 |
McLeod R, Lacko AG, Pritchard PH, Frohlich J. Purification of biologically active apolipoproteins by chromatofocussing Journal of Chromatography B: Biomedical Sciences and Applications. 381: 271-283. PMID 3760085 DOI: 10.1016/S0378-4347(00)83593-8 |
0.316 |
|
| 1986 |
Park YB, Lacko AG. Isolation and characterization of lecithin-cholesterol acyltransferase from hog plasma Biochimica Et Biophysica Acta (Bba)/Lipids and Lipid Metabolism. 877: 179-190. PMID 3718996 DOI: 10.1016/0005-2760(86)90133-5 |
0.389 |
|
| 1985 |
Park YB, Jahani M, Lacko AG. Isolation of high-density lipoproteins by immunoaffinity column chromatography from hog plasma Comparative Biochemistry and Physiology -- Part B: Biochemistry And. 82: 529-533. PMID 4085214 DOI: 10.1016/0305-0491(85)90018-5 |
0.361 |
|
| 1985 |
Carlile SI, Lacko AG. Age-related changes in plasma lipid levels and tissue lipoprotein lipase activities of Fischer-344 rats. Archives of Gerontology and Geriatrics. 4: 133-40. PMID 4037932 DOI: 10.1016/0167-4943(85)90027-5 |
0.32 |
|
| 1984 |
Lacko AG, Carlile S, Kudchodkar BJ. Evaluation of lipid and lipoprotein metabolism in rats as a model for studying age-related physiological changes. Journal of Gerontology. 39: 513-20. PMID 6470439 DOI: 10.1093/Geronj/39.5.513 |
0.327 |
|
| 1984 |
Park MC, McConathy WJ, Lacko AG. Effects of detergents on the lecithin: Cholesterol acyltransferase reaction Archives of Biochemistry and Biophysics. 233: 290-298. PMID 6431910 DOI: 10.1016/0003-9861(84)90628-3 |
0.328 |
|
| 1983 |
Chong KS, Hara S, Thompson RE, Lacko AG. Characterization of lecithin:Cholesterol acyltransferase from human plasma. II. Physical properties of the enzyme Archives of Biochemistry and Biophysics. 222: 553-560. PMID 6847201 DOI: 10.1016/0003-9861(83)90553-2 |
0.325 |
|
| 1983 |
Lacko AG, Hayes JD, McConathy WJ, Lacko I, Redheendran R. Lecithin: cholesterol acyltransferase in Down's syndrome Clinica Chimica Acta. 132: 133-141. PMID 6225568 DOI: 10.1016/0009-8981(83)90241-3 |
0.353 |
|
| 1982 |
Jahani M, Lacko AG. Study of the lecithin:Cholesterol acyltransferase reaction with liposome and high density lipoprotein substrates Biochimica Et Biophysica Acta (Bba)/Lipids and Lipid Metabolism. 713: 504-511. PMID 6817810 DOI: 10.1016/0005-2760(82)90310-1 |
0.412 |
|
| 1981 |
Chong KS, Davidson L, Huttash RG, Lacko AG. Characterization of lecithin:cholesterol acyltransferase from human plasma: Purification of the enzyme Archives of Biochemistry and Biophysics. 211: 119-124. PMID 7305362 DOI: 10.1016/0003-9861(81)90437-9 |
0.343 |
|
| 1981 |
Jahani M, Lacko AG. A study of the interaction of lecithin: Cholesterol acyltransferase with subfractions of high density lipoproteins Journal of Lipid Research. 22: 1102-1110. PMID 7299290 |
0.311 |
|
| 1980 |
Jahani M, Huttash RG, Lacko AG. A Novel Chromatographic Method for the Preparation of High Density Lipoproteins Preparative Biochemistry. 10: 431-444. PMID 6997859 DOI: 10.1080/00327488008061741 |
0.386 |
|
| 1980 |
Lacko AG. A test for the biochemical efficiency of isotopic cholesterol Lipids. 15: 983-985. DOI: 10.1007/Bf02534428 |
0.34 |
|
| 1979 |
Lacko AG, Davis JL. Age-related changes in rat and primate plasma cholesterol metabolism Journal of the American Geriatrics Society. 27: 212-217. PMID 219052 DOI: 10.1111/J.1532-5415.1979.Tb06034.X |
0.398 |
|
| 1976 |
Lacko AG. On the interpretation and potential diagnostic value of the measurements related to lecithin:cholesterol acyltransferase activity Clinical Biochemistry. 9: 212-215. PMID 954185 DOI: 10.1016/S0009-9120(76)80060-4 |
0.374 |
|
| 1976 |
David JSK, Soloff LA, Lacko AG. Factors affecting the esterification of lipoprotein cholesterol by lecithin: Cholesterol acyl transferase Life Sciences. 18: 701-706. PMID 177834 DOI: 10.1016/0024-3205(76)90181-8 |
0.33 |
|
| Show low-probability matches. |